Growth Metrics

Qiagen (QGEN) EPS (Weighted Average and Diluted) (2016 - 2026)

Qiagen's EPS (Weighted Average and Diluted) history spans 18 years, with the latest figure at $0.33 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 19.51% to $0.33 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.86, a 10.14% decrease, with the full-year FY2025 number at $1.94, up 424.32% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.33 in Q1 2026 for Qiagen, down from $0.49 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for QGEN hit a ceiling of $0.83 in Q2 2024 and a floor of $0.33 in Q1 2026.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.45 across 5 years, with a median of $0.41 in 2025.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 137.14% in 2024 and later tumbled 46.99% in 2025.
  • Tracing QGEN's EPS (Weighted Average and Diluted) over 5 years: stood at $0.39 in 2022, then increased by 7.69% to $0.42 in 2023, then dropped by 7.14% to $0.39 in 2024, then rose by 25.64% to $0.49 in 2025, then crashed by 32.65% to $0.33 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for QGEN at $0.33 in Q1 2026, $0.49 in Q4 2025, and $0.6 in Q3 2025.